COVID-19 Pandemic: Utilization and Aftermath of Telehealth Services
Keywords:telehealth reimbursement, strategic planning for telehealth companies, optimizing telehealth market success, telehealth regulatory issues, telehealth fraud
AbstractDiscussion focus on the top legal and regulatory issues affecting the delivery and reimbursement of telehealth services during the COVID-19 pandemic and how legislatures and government agencies at federal and state levels are responding in the aftermath to implement permanent changes and enforce fraudulent activities. The session provides valuable insights for startups and existing telemedicine practices seeking to understand strategic planning to optimize market success and maintain a compliant multi-state practice.
How to Cite
Copyright (c) 2022 Charles Dunham, Shareholder, Greenberg Traurig, LLP , Carolyn L. Yocom, Director, Health Care Team, US Government Accountability Office (GOA)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to Telehealth and Medicine Today (TMT).
TMT is published under a Creative Commons Attribution-NonCommercial 4.0 International License.